A mitochondrial-metabolism-regulatable carrier-free nanodrug to amplify the sensitivity of photothermal therapy.
Chem Commun (Camb)
; 57(71): 8993-8996, 2021 Sep 06.
Article
em En
| MEDLINE
| ID: mdl-34486606
ABSTRACT
The oxidative phosphorylation inhibitor atovaquone (ATO) and the photosensitizer new indocyanine green (IR820) were self-assembled into carrier-free nanodrugs (IR820/ATO NPs) to achieve superior photothermal therapy (PTT), offering an attractive mitochondrial metabolism-regulatable approach for breast cancer treatment, where adenosine triphosphate (ATP) was downregulated along with downregulating the expression of heat shock proteins (HSPs) to amplify the sensitivity of PTT.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Fármacos Fotossensibilizantes
/
Atovaquona
/
Nanopartículas
/
Verde de Indocianina
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article